Sales Growth YoY (Last 12 Months): Xencor, Inc. (XNCR)

Public company logo of Xencor Inc. (XNCR)

Geopolitical risks are complicating international trials and material supplies for Xencor, Inc. (XNCR). However, patent protection for molecules and licenses create a formidable barrier for competitors, while the XmAb platform accelerates the launch of new drugs. The year-over-year (12-month) relative revenue growth rate demonstrates the current resilience of the business model, with the indicator standing at 33.30, which defines the company's current development trend.

Xencor (XNCR) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Xencor (XNCR) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Xencor, Inc.
Product sample of xencor.com

Efficient resource allocation toward R&D and the successful licensing of Xencor, Inc. (XNCR) technologies establish a foundation for a stable capital inflow. By analyzing the year-over-year dynamics of commercial revenues on a rolling basis, investors can assess the daily revenue growth rate over 12 months compared to the same period last year, enabling a real-time assessment of actual demand for the issuer's products and the mitigation of risks associated with decelerating growth.

Competitors of Xencor, Inc. (XNCR)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)